Bluebird bio Inc

NASDAQ: BLUE
$0.90
+$0.05 (+5.3%)
Closing Price on June 21, 2024

BLUE Chart and Intraday Price

BLUE Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 60 BINNEY STREET, CAMBRIDGE, MA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 301.64M USD
Shares Outstanding 192,742,000
Bluebird bio Inc is a pioneering biotech firm focused on developing innovative gene therapies for severe genetic disorders. Its notable products include ZYNTEGLO for ß-thalassemia, a blood disorder; treatments for sickle cell disease; and SKYSONA for cerebral adrenoleukodystrophy, a rare brain condition. With a strong commitment to addressing unmet medical needs, Bluebird bio combines cutting-edge science with a deep understanding of genetic diseases to offer new hopes for patients. Founded in 1992 and based in Somerville, Massachusetts, the company continues to lead in the gene therapy space.

BLUE Articles

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with...
Thursday's top analyst upgrades and downgrades included Airbnb, Apple, Bluebird Bio, Cinemark, Cisco Systems, Coinbase Global, Etsy, Lyft, Microsoft, QuantumScape, Redfin, Snowflake and Starbucks.
Friday's top analyst upgrades and downgrades included Aramark, Bluebird Bio, Chevron, Chewy, CSX, C3.ai, Equitrans Midstream, Exxon Mobil, Macy’s, Micron Technology, Okta, Phillips 66 and Target.
Monday's top analyst upgrades and downgrades included Amazon.com, Bluebird Bio, Carnival, Fortinet, General Motors, Gilead Sciences, Hasbro, Hershey, Intel, International Paper, Masco, Mobileye...
Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Boeing, Coinbase Global, Costco Wholesale, Envista, Merck, New Fortress Energy, NexTier Oilfield Solutions, Radius Global...
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with...
Monday’s top analyst upgrades and downgrades included Applied Materials, Autodesk, BJ's Wholesale Club, Bluebird Bio, Domino’s Pizza, eBay, Foot Locker, Kohl's, Nasdaq, Salesforce, Snowflake,...
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with...
Wednesday’s top analyst upgrades and downgrades included Bluebird Bio, Caterpillar, Chesapeake Energy, Comstock Resources, Ford, Mosaic, On Semiconductor, Phillips 66, Plug Power, Ross Stores, Teva...
Here is another look at Beyond Meat, Bluebird Bio, Gap and other stocks that Wall Street analysts expected little from in the past week.
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Bluebird Bio, Dollar Tree, Diamondback Energy, Fastenal, Kohl's, Limelight Networks, Netflix, Palantir Technologies,...
Tuesay's top analyst upgrades and downgrades included AngloGold Ashanti, Ares Capital, Bank of America, Beyond Meat, Bluebird Bio, Coinbase Global, ConocoPhillips, Dell Technologies, Empire State...
Monday's top analyst upgrades and downgrades included Cinemark, Datadog, EOG Resources, Kellogg, Krispy Kreme, McAfee, Peloton Interactive, PulteGroup and Realty Income.
Tuesday's top analyst upgrades and downgrades included Akamai Technologies, Apple, Array Technologies, Clorox, Fastly, Fisker, Fiserv and Oracle.
Thursday’s top analyst upgrades and downgrades included AutoNation, Enbridge, Gap, JinkoSolar, Micron Technology, Nvidia, Tractor Supply, Twilio and Vertex Pharmaceuticals.